 | • レポートコード：QYR2104Z3242 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、体外診断サービスのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（感染症検査、糖尿病検査、分子検査、組織検査）、用途別市場規模（病院、ポイントオブケア検査、研究所、学術機関）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・体外診断サービスの市場動向 ・企業の競争状況、市場シェア ・体外診断サービスの種類別市場規模（感染症検査、糖尿病検査、分子検査、組織検査） ・体外診断サービスの用途別市場規模（病院、ポイントオブケア検査、研究所、学術機関） ・体外診断サービスの北米市場規模2016-2027（アメリカ、カナダ） ・体外診断サービスのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・体外診断サービスのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・体外診断サービスの中南米市場規模2016-2027（メキシコ、ブラジル） ・体外診断サービスの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（BioRad、DexCom、Nova Biomedical、OraSure、Pearl Pathways、Phenomenex、Qiagen、Roche Diagnostics、Siemens、Sysmex、Thermofisher） ・結論 |
In vitro diagnostics are tests done on samples such as blood or tissue that have been taken from the human body. In vitro diagnostics can detect diseases or other conditions, and can be used to monitor a person’s overall health to help cure, treat, or prevent diseases.
In vitro diagnostics may also be used in precision medicine to identify patients who are likely to benefit from specific treatments or therapies. These in vitro diagnostics can include next generation sequencing tests, which scan a person’s DNA to detect genomic variations.
Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.
Market Analysis and Insights: Global In-vitro Diagnostic Services Market
The global In-vitro Diagnostic Services market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global In-vitro Diagnostic Services market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global In-vitro Diagnostic Services market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global In-vitro Diagnostic Services market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global In-vitro Diagnostic Services market.
Global In-vitro Diagnostic Services Scope and Market Size
In-vitro Diagnostic Services market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global In-vitro Diagnostic Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Infectious Testing
Diabetes Testing
Molecular Testing
Tissue Testing
Segment by Application
Hospitals
Point-Of-Care Testing
Laboratories
Academic Institutes
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
BioRad
DexCom
Nova Biomedical
OraSure
Pearl Pathways
Phenomenex
Qiagen
Roche Diagnostics
Siemens
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-vitro Diagnostic Services Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Infectious Testing
1.2.3 Diabetes Testing
1.2.4 Molecular Testing
1.2.5 Tissue Testing
1.3 Market by Application
1.3.1 Global In-vitro Diagnostic Services Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Point-Of-Care Testing
1.3.4 Laboratories
1.3.5 Academic Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global In-vitro Diagnostic Services Market Perspective (2016-2027)
2.2 In-vitro Diagnostic Services Growth Trends by Regions
2.2.1 In-vitro Diagnostic Services Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 In-vitro Diagnostic Services Historic Market Share by Regions (2016-2021)
2.2.3 In-vitro Diagnostic Services Forecasted Market Size by Regions (2022-2027)
2.3 In-vitro Diagnostic Services Industry Dynamic
2.3.1 In-vitro Diagnostic Services Market Trends
2.3.2 In-vitro Diagnostic Services Market Drivers
2.3.3 In-vitro Diagnostic Services Market Challenges
2.3.4 In-vitro Diagnostic Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-vitro Diagnostic Services Players by Revenue
3.1.1 Global Top In-vitro Diagnostic Services Players by Revenue (2016-2021)
3.1.2 Global In-vitro Diagnostic Services Revenue Market Share by Players (2016-2021)
3.2 Global In-vitro Diagnostic Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by In-vitro Diagnostic Services Revenue
3.4 Global In-vitro Diagnostic Services Market Concentration Ratio
3.4.1 Global In-vitro Diagnostic Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-vitro Diagnostic Services Revenue in 2020
3.5 In-vitro Diagnostic Services Key Players Head office and Area Served
3.6 Key Players In-vitro Diagnostic Services Product Solution and Service
3.7 Date of Enter into In-vitro Diagnostic Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In-vitro Diagnostic Services Breakdown Data by Type
4.1 Global In-vitro Diagnostic Services Historic Market Size by Type (2016-2021)
4.2 Global In-vitro Diagnostic Services Forecasted Market Size by Type (2022-2027)
5 In-vitro Diagnostic Services Breakdown Data by Application
5.1 Global In-vitro Diagnostic Services Historic Market Size by Application (2016-2021)
5.2 Global In-vitro Diagnostic Services Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America In-vitro Diagnostic Services Market Size (2016-2027)
6.2 North America In-vitro Diagnostic Services Market Size by Type
6.2.1 North America In-vitro Diagnostic Services Market Size by Type (2016-2021)
6.2.2 North America In-vitro Diagnostic Services Market Size by Type (2022-2027)
6.2.3 North America In-vitro Diagnostic Services Market Size by Type (2016-2027)
6.3 North America In-vitro Diagnostic Services Market Size by Application
6.3.1 North America In-vitro Diagnostic Services Market Size by Application (2016-2021)
6.3.2 North America In-vitro Diagnostic Services Market Size by Application (2022-2027)
6.3.3 North America In-vitro Diagnostic Services Market Size by Application (2016-2027)
6.4 North America In-vitro Diagnostic Services Market Size by Country
6.4.1 North America In-vitro Diagnostic Services Market Size by Country (2016-2021)
6.4.2 North America In-vitro Diagnostic Services Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe In-vitro Diagnostic Services Market Size (2016-2027)
7.2 Europe In-vitro Diagnostic Services Market Size by Type
7.2.1 Europe In-vitro Diagnostic Services Market Size by Type (2016-2021)
7.2.2 Europe In-vitro Diagnostic Services Market Size by Type (2022-2027)
7.2.3 Europe In-vitro Diagnostic Services Market Size by Type (2016-2027)
7.3 Europe In-vitro Diagnostic Services Market Size by Application
7.3.1 Europe In-vitro Diagnostic Services Market Size by Application (2016-2021)
7.3.2 Europe In-vitro Diagnostic Services Market Size by Application (2022-2027)
7.3.3 Europe In-vitro Diagnostic Services Market Size by Application (2016-2027)
7.4 Europe In-vitro Diagnostic Services Market Size by Country
7.4.1 Europe In-vitro Diagnostic Services Market Size by Country (2016-2021)
7.4.2 Europe In-vitro Diagnostic Services Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific In-vitro Diagnostic Services Market Size (2016-2027)
8.2 Asia-Pacific In-vitro Diagnostic Services Market Size by Type
8.2.1 Asia-Pacific In-vitro Diagnostic Services Market Size by Type (2016-2021)
8.2.2 Asia-Pacific In-vitro Diagnostic Services Market Size by Type (2022-2027)
8.2.3 Asia-Pacific In-vitro Diagnostic Services Market Size by Type (2016-2027)
8.3 Asia-Pacific In-vitro Diagnostic Services Market Size by Application
8.3.1 Asia-Pacific In-vitro Diagnostic Services Market Size by Application (2016-2021)
8.3.2 Asia-Pacific In-vitro Diagnostic Services Market Size by Application (2022-2027)
8.3.3 Asia-Pacific In-vitro Diagnostic Services Market Size by Application (2016-2027)
8.4 Asia-Pacific In-vitro Diagnostic Services Market Size by Region
8.4.1 Asia-Pacific In-vitro Diagnostic Services Market Size by Region (2016-2021)
8.4.2 Asia-Pacific In-vitro Diagnostic Services Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America In-vitro Diagnostic Services Market Size (2016-2027)
9.2 Latin America In-vitro Diagnostic Services Market Size by Type
9.2.1 Latin America In-vitro Diagnostic Services Market Size by Type (2016-2021)
9.2.2 Latin America In-vitro Diagnostic Services Market Size by Type (2022-2027)
9.2.3 Latin America In-vitro Diagnostic Services Market Size by Type (2016-2027)
9.3 Latin America In-vitro Diagnostic Services Market Size by Application
9.3.1 Latin America In-vitro Diagnostic Services Market Size by Application (2016-2021)
9.3.2 Latin America In-vitro Diagnostic Services Market Size by Application (2022-2027)
9.3.3 Latin America In-vitro Diagnostic Services Market Size by Application (2016-2027)
9.4 Latin America In-vitro Diagnostic Services Market Size by Country
9.4.1 Latin America In-vitro Diagnostic Services Market Size by Country (2016-2021)
9.4.2 Latin America In-vitro Diagnostic Services Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-vitro Diagnostic Services Market Size (2016-2027)
10.2 Middle East & Africa In-vitro Diagnostic Services Market Size by Type
10.2.1 Middle East & Africa In-vitro Diagnostic Services Market Size by Type (2016-2021)
10.2.2 Middle East & Africa In-vitro Diagnostic Services Market Size by Type (2022-2027)
10.2.3 Middle East & Africa In-vitro Diagnostic Services Market Size by Type (2016-2027)
10.3 Middle East & Africa In-vitro Diagnostic Services Market Size by Application
10.3.1 Middle East & Africa In-vitro Diagnostic Services Market Size by Application (2016-2021)
10.3.2 Middle East & Africa In-vitro Diagnostic Services Market Size by Application (2022-2027)
10.3.3 Middle East & Africa In-vitro Diagnostic Services Market Size by Application (2016-2027)
10.4 Middle East & Africa In-vitro Diagnostic Services Market Size by Country
10.4.1 Middle East & Africa In-vitro Diagnostic Services Market Size by Country (2016-2021)
10.4.2 Middle East & Africa In-vitro Diagnostic Services Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 BioRad
11.1.1 BioRad Company Details
11.1.2 BioRad Business Overview
11.1.3 BioRad In-vitro Diagnostic Services Introduction
11.1.4 BioRad Revenue in In-vitro Diagnostic Services Business (2016-2021)
11.1.5 BioRad Recent Development
11.2 DexCom
11.2.1 DexCom Company Details
11.2.2 DexCom Business Overview
11.2.3 DexCom In-vitro Diagnostic Services Introduction
11.2.4 DexCom Revenue in In-vitro Diagnostic Services Business (2016-2021)
11.2.5 DexCom Recent Development
11.3 Nova Biomedical
11.3.1 Nova Biomedical Company Details
11.3.2 Nova Biomedical Business Overview
11.3.3 Nova Biomedical In-vitro Diagnostic Services Introduction
11.3.4 Nova Biomedical Revenue in In-vitro Diagnostic Services Business (2016-2021)
11.3.5 Nova Biomedical Recent Development
11.4 OraSure
11.4.1 OraSure Company Details
11.4.2 OraSure Business Overview
11.4.3 OraSure In-vitro Diagnostic Services Introduction
11.4.4 OraSure Revenue in In-vitro Diagnostic Services Business (2016-2021)
11.4.5 OraSure Recent Development
11.5 Pearl Pathways
11.5.1 Pearl Pathways Company Details
11.5.2 Pearl Pathways Business Overview
11.5.3 Pearl Pathways In-vitro Diagnostic Services Introduction
11.5.4 Pearl Pathways Revenue in In-vitro Diagnostic Services Business (2016-2021)
11.5.5 Pearl Pathways Recent Development
11.6 Phenomenex
11.6.1 Phenomenex Company Details
11.6.2 Phenomenex Business Overview
11.6.3 Phenomenex In-vitro Diagnostic Services Introduction
11.6.4 Phenomenex Revenue in In-vitro Diagnostic Services Business (2016-2021)
11.6.5 Phenomenex Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen In-vitro Diagnostic Services Introduction
11.7.4 Qiagen Revenue in In-vitro Diagnostic Services Business (2016-2021)
11.7.5 Qiagen Recent Development
11.8 Roche Diagnostics
11.8.1 Roche Diagnostics Company Details
11.8.2 Roche Diagnostics Business Overview
11.8.3 Roche Diagnostics In-vitro Diagnostic Services Introduction
11.8.4 Roche Diagnostics Revenue in In-vitro Diagnostic Services Business (2016-2021)
11.8.5 Roche Diagnostics Recent Development
11.9 Siemens
11.9.1 Siemens Company Details
11.9.2 Siemens Business Overview
11.9.3 Siemens In-vitro Diagnostic Services Introduction
11.9.4 Siemens Revenue in In-vitro Diagnostic Services Business (2016-2021)
11.9.5 Siemens Recent Development
11.10 Sysmex
11.10.1 Sysmex Company Details
11.10.2 Sysmex Business Overview
11.10.3 Sysmex In-vitro Diagnostic Services Introduction
11.10.4 Sysmex Revenue in In-vitro Diagnostic Services Business (2016-2021)
11.10.5 Sysmex Recent Development
11.11 Thermofisher
11.11.1 Thermofisher Company Details
11.11.2 Thermofisher Business Overview
11.11.3 Thermofisher In-vitro Diagnostic Services Introduction
11.11.4 Thermofisher Revenue in In-vitro Diagnostic Services Business (2016-2021)
11.11.5 Thermofisher Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global In-vitro Diagnostic Services Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Infectious Testing
Table 3. Key Players of Diabetes Testing
Table 4. Key Players of Molecular Testing
Table 5. Key Players of Tissue Testing
Table 6. Global In-vitro Diagnostic Services Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global In-vitro Diagnostic Services Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global In-vitro Diagnostic Services Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global In-vitro Diagnostic Services Market Share by Regions (2016-2021)
Table 10. Global In-vitro Diagnostic Services Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global In-vitro Diagnostic Services Market Share by Regions (2022-2027)
Table 12. In-vitro Diagnostic Services Market Trends
Table 13. In-vitro Diagnostic Services Market Drivers
Table 14. In-vitro Diagnostic Services Market Challenges
Table 15. In-vitro Diagnostic Services Market Restraints
Table 16. Global In-vitro Diagnostic Services Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global In-vitro Diagnostic Services Market Share by Players (2016-2021)
Table 18. Global Top In-vitro Diagnostic Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In-vitro Diagnostic Services as of 2020)
Table 19. Ranking of Global Top In-vitro Diagnostic Services Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by In-vitro Diagnostic Services Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players In-vitro Diagnostic Services Product Solution and Service
Table 23. Date of Enter into In-vitro Diagnostic Services Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global In-vitro Diagnostic Services Market Size by Type (2016-2021) (US$ Million)
Table 26. Global In-vitro Diagnostic Services Revenue Market Share by Type (2016-2021)
Table 27. Global In-vitro Diagnostic Services Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global In-vitro Diagnostic Services Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global In-vitro Diagnostic Services Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global In-vitro Diagnostic Services Revenue Market Share by Application (2016-2021)
Table 31. Global In-vitro Diagnostic Services Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global In-vitro Diagnostic Services Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America In-vitro Diagnostic Services Market Size by Type (2016-2021) (US$ Million)
Table 34. North America In-vitro Diagnostic Services Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America In-vitro Diagnostic Services Market Size by Application (2016-2021) (US$ Million)
Table 36. North America In-vitro Diagnostic Services Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America In-vitro Diagnostic Services Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America In-vitro Diagnostic Services Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe In-vitro Diagnostic Services Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe In-vitro Diagnostic Services Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe In-vitro Diagnostic Services Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe In-vitro Diagnostic Services Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe In-vitro Diagnostic Services Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe In-vitro Diagnostic Services Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific In-vitro Diagnostic Services Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific In-vitro Diagnostic Services Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific In-vitro Diagnostic Services Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific In-vitro Diagnostic Services Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific In-vitro Diagnostic Services Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific In-vitro Diagnostic Services Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America In-vitro Diagnostic Services Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America In-vitro Diagnostic Services Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America In-vitro Diagnostic Services Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America In-vitro Diagnostic Services Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America In-vitro Diagnostic Services Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America In-vitro Diagnostic Services Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa In-vitro Diagnostic Services Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa In-vitro Diagnostic Services Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa In-vitro Diagnostic Services Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa In-vitro Diagnostic Services Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa In-vitro Diagnostic Services Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa In-vitro Diagnostic Services Market Size by Country (2022-2027) & (US$ Million)
Table 63. BioRad Company Details
Table 64. BioRad Business Overview
Table 65. BioRad In-vitro Diagnostic Services Product
Table 66. BioRad Revenue in In-vitro Diagnostic Services Business (2016-2021) & (US$ Million)
Table 67. BioRad Recent Development
Table 68. DexCom Company Details
Table 69. DexCom Business Overview
Table 70. DexCom In-vitro Diagnostic Services Product
Table 71. DexCom Revenue in In-vitro Diagnostic Services Business (2016-2021) & (US$ Million)
Table 72. DexCom Recent Development
Table 73. Nova Biomedical Company Details
Table 74. Nova Biomedical Business Overview
Table 75. Nova Biomedical In-vitro Diagnostic Services Product
Table 76. Nova Biomedical Revenue in In-vitro Diagnostic Services Business (2016-2021) & (US$ Million)
Table 77. Nova Biomedical Recent Development
Table 78. OraSure Company Details
Table 79. OraSure Business Overview
Table 80. OraSure In-vitro Diagnostic Services Product
Table 81. OraSure Revenue in In-vitro Diagnostic Services Business (2016-2021) & (US$ Million)
Table 82. OraSure Recent Development
Table 83. Pearl Pathways Company Details
Table 84. Pearl Pathways Business Overview
Table 85. Pearl Pathways In-vitro Diagnostic Services Product
Table 86. Pearl Pathways Revenue in In-vitro Diagnostic Services Business (2016-2021) & (US$ Million)
Table 87. Pearl Pathways Recent Development
Table 88. Phenomenex Company Details
Table 89. Phenomenex Business Overview
Table 90. Phenomenex In-vitro Diagnostic Services Product
Table 91. Phenomenex Revenue in In-vitro Diagnostic Services Business (2016-2021) & (US$ Million)
Table 92. Phenomenex Recent Development
Table 93. Qiagen Company Details
Table 94. Qiagen Business Overview
Table 95. Qiagen In-vitro Diagnostic Services Product
Table 96. Qiagen Revenue in In-vitro Diagnostic Services Business (2016-2021) & (US$ Million)
Table 97. Qiagen Recent Development
Table 98. Roche Diagnostics Company Details
Table 99. Roche Diagnostics Business Overview
Table 100. Roche Diagnostics Revenue in In-vitro Diagnostic Services Business (2016-2021) & (US$ Million)
Table 101. Roche Diagnostics Recent Development
Table 102. Siemens Company Details
Table 103. Siemens Business Overview
Table 104. Siemens In-vitro Diagnostic Services Product
Table 105. Siemens Revenue in In-vitro Diagnostic Services Business (2016-2021) & (US$ Million)
Table 106. Siemens Recent Development
Table 107. Sysmex Company Details
Table 108. Sysmex Business Overview
Table 109. Sysmex In-vitro Diagnostic Services Product
Table 110. Sysmex Revenue in In-vitro Diagnostic Services Business (2016-2021) & (US$ Million)
Table 111. Sysmex Recent Development
Table 112. Thermofisher Company Details
Table 113. Thermofisher Business Overview
Table 114. Thermofisher In-vitro Diagnostic Services Product
Table 115. Thermofisher Revenue in In-vitro Diagnostic Services Business (2016-2021) & (US$ Million)
Table 116. Thermofisher Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In-vitro Diagnostic Services Market Share by Type: 2020 VS 2027
Figure 2. Infectious Testing Features
Figure 3. Diabetes Testing Features
Figure 4. Molecular Testing Features
Figure 5. Tissue Testing Features
Figure 6. Global In-vitro Diagnostic Services Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Point-Of-Care Testing Case Studies
Figure 9. Laboratories Case Studies
Figure 10. Academic Institutes Case Studies
Figure 11. In-vitro Diagnostic Services Report Years Considered
Figure 12. Global In-vitro Diagnostic Services Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global In-vitro Diagnostic Services Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global In-vitro Diagnostic Services Market Share by Regions: 2020 VS 2027
Figure 15. Global In-vitro Diagnostic Services Market Share by Regions (2022-2027)
Figure 16. Global In-vitro Diagnostic Services Market Share by Players in 2020
Figure 17. Global Top In-vitro Diagnostic Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In-vitro Diagnostic Services as of 2020
Figure 18. The Top 10 and 5 Players Market Share by In-vitro Diagnostic Services Revenue in 2020
Figure 19. Global In-vitro Diagnostic Services Revenue Market Share by Type (2016-2021)
Figure 20. Global In-vitro Diagnostic Services Revenue Market Share by Type (2022-2027)
Figure 21. North America In-vitro Diagnostic Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America In-vitro Diagnostic Services Market Share by Type (2016-2027)
Figure 23. North America In-vitro Diagnostic Services Market Share by Application (2016-2027)
Figure 24. North America In-vitro Diagnostic Services Market Share by Country (2016-2027)
Figure 25. United States In-vitro Diagnostic Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada In-vitro Diagnostic Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe In-vitro Diagnostic Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe In-vitro Diagnostic Services Market Share by Type (2016-2027)
Figure 29. Europe In-vitro Diagnostic Services Market Share by Application (2016-2027)
Figure 30. Europe In-vitro Diagnostic Services Market Share by Country (2016-2027)
Figure 31. Germany In-vitro Diagnostic Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France In-vitro Diagnostic Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. In-vitro Diagnostic Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy In-vitro Diagnostic Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia In-vitro Diagnostic Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic In-vitro Diagnostic Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific In-vitro Diagnostic Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific In-vitro Diagnostic Services Market Share by Type (2016-2027)
Figure 39. Asia-Pacific In-vitro Diagnostic Services Market Share by Application (2016-2027)
Figure 40. Asia-Pacific In-vitro Diagnostic Services Market Share by Region (2016-2027)
Figure 41. China In-vitro Diagnostic Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan In-vitro Diagnostic Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea In-vitro Diagnostic Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia In-vitro Diagnostic Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India In-vitro Diagnostic Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia In-vitro Diagnostic Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America In-vitro Diagnostic Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America In-vitro Diagnostic Services Market Share by Type (2016-2027)
Figure 49. Latin America In-vitro Diagnostic Services Market Share by Application (2016-2027)
Figure 50. Latin America In-vitro Diagnostic Services Market Share by Country (2016-2027)
Figure 51. Mexico In-vitro Diagnostic Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil In-vitro Diagnostic Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa In-vitro Diagnostic Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa In-vitro Diagnostic Services Market Share by Type (2016-2027)
Figure 55. Middle East & Africa In-vitro Diagnostic Services Market Share by Application (2016-2027)
Figure 56. Middle East & Africa In-vitro Diagnostic Services Market Share by Country (2016-2027)
Figure 57. Turkey In-vitro Diagnostic Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia In-vitro Diagnostic Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE In-vitro Diagnostic Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. BioRad Revenue Growth Rate in In-vitro Diagnostic Services Business (2016-2021)
Figure 61. DexCom Revenue Growth Rate in In-vitro Diagnostic Services Business (2016-2021)
Figure 62. Nova Biomedical Revenue Growth Rate in In-vitro Diagnostic Services Business (2016-2021)
Figure 63. OraSure Revenue Growth Rate in In-vitro Diagnostic Services Business (2016-2021)
Figure 64. Pearl Pathways Revenue Growth Rate in In-vitro Diagnostic Services Business (2016-2021)
Figure 65. Phenomenex Revenue Growth Rate in In-vitro Diagnostic Services Business (2016-2021)
Figure 66. Qiagen Revenue Growth Rate in In-vitro Diagnostic Services Business (2016-2021)
Figure 67. Roche Diagnostics Revenue Growth Rate in In-vitro Diagnostic Services Business (2016-2021)
Figure 68. Siemens Revenue Growth Rate in In-vitro Diagnostic Services Business (2016-2021)
Figure 69. Sysmex Revenue Growth Rate in In-vitro Diagnostic Services Business (2016-2021)
Figure 70. Thermofisher Revenue Growth Rate in In-vitro Diagnostic Services Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界のIVD（体外診断）検査市場規模・現状・予測（2021年-2027年） In-vitro diagnostics (IVD) are used to detect diseases, infections, and conditions and also monitor a person’s state of health and therapeutic procedures by examining specimens derived from the human body such as tissue, blood, stools, urine and the other body fluids. Significant technologies incorp…- 世界のIVD（体外診断）検査市場規模・現状・予測（2021年-2027年） In-vitro diagnostics (IVD) are used to detect diseases, infections, and conditions and also monitor a person’s state of health and therapeutic procedures by examining specimens derived from the human body such as tissue, blood, stools, urine and the other body fluids. Significant technologies incorp…
- 世界の医療用In-Vitro毒性試験市場規模・現状・予測（2021年-2027年） The main purpose is to guide the clinical rational use of drugs, reduce adverse drug reactions and reduce the failure of new drug development due to drug toxicity. Market Analysis and Insights: Global Medical In-Vitro Toxicology Testing Market The global Medical In-Vitro Toxicology Testing market si…
- 世界の医療用In-Vitro毒性試験市場規模・現状・予測（2021年-2027年） The main purpose is to guide the clinical rational use of drugs, reduce adverse drug reactions and reduce the failure of new drug development due to drug toxicity. Market Analysis and Insights: Global Medical In-Vitro Toxicology Testing Market The global Medical In-Vitro Toxicology Testing market si…
- 世界の感染症検査・診断市場規模・現状・予測（2021年-2027年） Infectious disease testing is the process of identification of causative organisms for the primary diagnosis of diseases. Market Analysis and Insights: Global Infectious Disease Testing And Diagnostic Market The global Infectious Disease Testing And Diagnostic market size is projected to reach US$ X…